COLLEEN GLEASON: Open Payments
NPI 1215921333 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 56 payments from 11 companies in 2025. Trend: 2023 $821 · 2024 $877 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $311 |
| Janssen Biotech, Inc. | 11 | $138 |
| GlaxoSmithKline, LLC. | 1 | $118 |
| Aurinia Pharma U.S., Inc. | 1 | $118 |
| Amgen Inc. | 6 | $107 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| KYOWA KIRIN, INC. | 1 | $21 |
Products named: RINVOQ, TREMFYA, SKYRIZI, BENLYSTA, LUPKYNIS, COSENTYX, OTEZLA, KRYSTEXXA.
Industry payments across CA — which companies pay providers there.
